CALL/MERCK & CO./200/0.1/20.09.24 Stock

DE000GG6DGC9

Market Closed - BOERSE MUENCHEN 02:27:00 2024-06-28 pm EDT
0.007 ^EUR	-12.50%

Current month	-50.00%
1 month	+75.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart MERCK & CO., INC.

Latest news about MERCK & CO., INC.

CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE for Pneumococcal Vaccination in Appropriate Adults	Jun. 28	AQ
EISAI - NEW EFFICACY DATA FOR NON-CLEAR CELL RENAL CELL CARCINOMA FROM KEYNOTE-B61 ADDED TO LENVIMA US LABEL SUPPORTING KEYTRUDA + LENVIMA INDICATION FOR THE FIRST-LINE TREATMENT OF ADULT PATIENTS WITH ADVANCED RCC	Jun. 28	AQ
Immutep Reports Positive Topline Results from TACTI-003 Phase IIb Trial in First Line Head and Neck Cancer	Jun. 28	AQ
Merck: positive opinion for Winrevair in Europe	Jun. 28	CF

More news

Quotes 5-day view

Date	Price	Change
24-06-28	0.007	-12.50%
24-06-27	0.008	0.00%
24-06-26	0.008	+14.29%
24-06-25	0.007	+16.67%
24-06-24	0.006	-25.00%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 02:27 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	MERCK & CO., INC.
Issuer	Goldman Sachs
WKN	GG6DGC
ISIN	DE000GG6DGC9
Date issued	2024-04-02
Strike	200 $
Maturity	2024-09-20 (83 Days)
Parity	10 : 1
Emission price	0.01 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.014 €
Lowest since issue	0.002 €
Spread	0.03 €
Spread %	83.33%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).

Sector

More about the company

Ratings for Merck & Co., Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Merck & Co., Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

123.8 USD

Average target price

142.7 USD

Spread / Average Target

+15.25%

Consensus